| Résumé : |
An invention concerning EP0797427 particularly relates to active compounds and formulations, in particular for topical use, which are used for prophylaxis and treatment of hyperreactive skin predisposed to dermatitis, and of deficient hypoactive skin and for prophylaxis and treatment of the manifest dermatoses mentioned under I. to XIII., such as, for example, atopic dermatitis, neurodermatitis, atopic eczema and seborrhoeic dermatitis, photoinduced dermatoses (for example Mallorca acne and in particular polymorphic photodermatitis), rosacea, prurigo forms, pruritus, sporiasis form, ichthyosis, decubitus, ulcus cruris and microbial and viral infections, such as, for example, herpes simplex, h.zoster or h.labialis. |
Aller sur edunet
Accueil
Agents against hyperreactive and hypoactive, deficiency states of the skin and manifest dermatitits in SOFW JOURNAL, Vol. 129, N° 7 (07/2003)
